Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans

Vaccine

Volumn 30, Issue 18, 2012, Pages 2900-2907

  Khan, M Nadeem ^a   Pichichero, Michael E ^a  

^a ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

ADHESIN; Aggregation; Colonization; Pneumococi; Protection; Vaccination

Indexed keywords

ADHESIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN PHTD ANTIBODY; RECOMBINANT PROTEIN PHTE ANTIBODY; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM MUTANT; CELL ADHESION; CELL AGGREGATION; CELL COUNT; CELL LINE; CHILD; CONFOCAL MICROSCOPY; EPITHELIUM CELL; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIAE;

ADHESINS, BACTERIAL; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; CELL LINE; CHILD, PRESCHOOL; EPITHELIAL CELLS; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN G; INFANT; MICROSCOPY, CONFOCAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RECOMBINANT PROTEINS; STREPTOCOCCUS PNEUMONIAE;

EID: 84863400976     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.023     Document Type: Article

References (41)

1. Paton J.C. New pneumococcal vaccines: basic science developments. The pneumococcus 2004, 382-402. ASM Press, Washington, DC. E.I. Tuomanen, T.J. Mitchell, D.A. Morrison, B.G. Spratt (Eds.).
2. Bogaert D., de Grott R., Hermans P. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
3. Rajam G., Anderton J.M., Carlone G.M., Sampson J.S., Ades E.W. Pneumococcal surface adhesin A (PsaA): a review. Crit Rev Microbiol 2008, 34:163-173.
4. Rosenow C., Ryan P., Weiser J.N., Johnson S., Fontan P., Ortqvist A., et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 1997, 25(5):819-829.
5. Pracht D., Elm C., Gerber J., Bergmann S., Rohde M., Seiler M., et al. PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun 2005, 73(5):2680-2689.
6. Rose L., Shivshankar P., Hinojosa E., Rodriguez A., Sanchez C.J., Orihuela C.J. Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block adhesion and protect mice against pneumococcal challenge. J Infect Dis 2008, 198(3):375-383.
7. Golda A., Malek N., Dudek B., Zeglen S., Wojarski J., Ochman M., et al. Infection with human coronavirus NL63 enhances streptococcal adherence to epithelial cells. J Gen Virol 2011, 92:1358-1368.
8. Zhang J.R., Mostov K.E., Lamm M.E., Nanno M., Shimida S., Ohwaki M., et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000, 102(6):827-837.
9. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006, 19(3):571-582.
10. Black S.B., Shinefield H.R., Ling S., Hansen J., Fireman B., Spring D., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002, 21:810-816.
11. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001, 344:403-409.
12. Obaro S., Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 2002, 51:98-104.
13. Hamel J., Charland N., Pineau I., Ouellet C., Rioux S., Martin D., et al. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins. Infect Immun 2004, 72:2659-2670.
14. Adamou J.E., Heinrichs J.H., Erwin A.L., Walsh W., Gayle T., Dormitzer M., et al. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun 2001, 69:949-958.
15. Beghetto E., Gargano N., Ricci S., Garufi G., Peppoloni S., Montagnani F., et al. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library. FEMS Microbiol Lett 2006, 262:14-21.
16. Ogunniyi A.D., Grabowicz M., Briles D.E., Cook J., Paton J.C. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun 2007, 75:350-357.
17. Melin M., Di Paolo E., Tikkanen L., Jarva H., Neyt C., Kayhty H., et al. Interaction of pneumococcal histidine triad proteins with human complement. Infect Immun 2010, 78:2089-2098.
18. Kaur R., Casey J.R., Pichichero M.E. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediatr Infect Dis J 2011, 30(8):645-650.
19. Holmlund E., Quiambao B., Ollgren J., Jaakkola T., Neyt C., Poolman J., et al. Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage. Clin Vaccine Immunol 2009, 16(6):916-923.
20. Panina E.M., Mironov A.A., Gelfand M.S. Comparative genomics of bacterial zinc regulons: enhanced ion transport, pathogenesis, and rearrangement of ribosomal proteins. Proc Natl Acad Sci U S A 2003, 100:9912-9917.
21. Rioux S., Neyt C., Di Paolo E., Turpin L., Charland N., Labbé S., et al. Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae. Microbiology 2011, 157:336-348.
22. Ragheb R., Abrahams S., Beecroft R., Hu J., Ni J., Ramakrishna V., et al. Preparation and functional properties of monoclonal antibodies to human, mouse and rat OX-2. Immunol Lett 1999, 168:311-315.
23. Kloosterman T.G., Bijlsma J.J., Kok J., Kuipers O.P. To have neighbour's fare: extending the molecular toolbox for Streptococcus pneumoniae. Microbiology 2006, 152:351-359.
24. Cullen P.A., Lo M., Bulach D.M., Cordwell S.J., Adler B. Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli. Plasmid 2003, 49(1):18-29.
25. Raybourne R.B., Bunning V.K. Bacterium-host cell interactions at the cellular level: fluorescent labeling of bacteria and analysis of short-term bacterium-phagocyte interaction by flow cytometry. Infect Immun 1994, 62:665-672.
26. Fabrizio K., Manix C., Guimaraes A.J., Nosanchuk J.D., Pirofski L.A. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo. Clin Vaccine Immunol 2010, 17:713-721.
27. Hara-Kaonga B., Pistole T.G. A dual fluorescence flow cytometric analysis of bacterial adherence to mammalian host cells. J Microbiol Methods 2007, 69:37-43.
28. Chen S.M., Tsai Y.S., Wu C.M., et al. Streptococcal collagen-like surface protein 1 promotes adhesion to the respiratory epithelial cell. BMC Microbiol 2010, 10:320.
29. Timpe J.M., Holm M.M., Vanlerberg S.L., Basrur V., Lafontaine E.R. Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities. Infect Immun 2003, 71:4341-4350.
30. Jensch I., Gamez G., Rothe M., et al. PavB is a surface-exposed adhesin of Streptococcus pneumoniae contributing to nasopharyngeal colonization and airways infections. Mol Microbiol 2010, 77:22-43.
31. Tuomanen E.I., Austrian R., Masure H.R. Pathogenesis of pneumococcal infection. N Engl J Med 1995, 332:1280-1284.
32. Richards L., Ferreira D.M., Miyaji E.N., Andrew P.W., Kadioglu A. The immunising effect of pneumococcal nasopharyngeal colonisation: protection against future colonisation and fatal invasive disease. Immunobiology 2010, 215(4):251-263.
33. McCool T.L., Cate T.R., Moy G., Weiser J.N. The immune response to pneumococcal proteins during experimental human carriage. J Exp Med 2002, 195(3):359-365.
34. Bakaletz L.O., Leake E.R., Billy J.M., Kaumaya P.T. Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla. Vaccine 1997, 15(9):955-961.
35. Hava D.L., Camilli A. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 2002, 45:1389-1406.
36. Ogunniyi A.D., Grabowicz M., Mahdi L.K., Cook J., Gordon D.L., Sadlon T.A., et al. Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB J 2009, 23:731-738.
37. Godfroid F., Hermand P., Verlant V., Denoël P., Poolman J.T. Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun 2011, 79(1):238-245.
38. Romero-Steiner S., Pilishvili T., Sampson J.S., Johnson S.E., Stinson A., Carlone G.M., et al. Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies. Clin Diagn Lab Immunol 2003, 10(2):246-251.
39. Harris S.L., King W.J., Ferris W., Granoff D.M. Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine. Infect Immun 2003, 71(1):275-286.
40. Pollard A.J., Levin M. Production of low-avidity antibody by infants after infection with serogroup B meningococci. Lancet 2010, 356:2065-2066.
41. Usinger W.R., Lucas A.H. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. Infect Immun 1999, 67:2366-2370.